erlotinib - Globe Thesis

Keyword [erlotinib] Result: 21 - 40 \| Page: 2 of 8
21.	The Effect And Mechanism Of Autophagy In Inhibiting The Proliferation Of A549 Cells Induced By Rh-endostatin And Erlotinib
22.	Study Of The Effect Of Aqueous Extract Of Taxus Chinensis On Human Lung A549 Cell And Which Combined With Erlotinib EGFR Expression
23.	Exploration Of Expression And Significance Of C-Met And Soluble Met In Lung Cancer
24.	Regulation Of MiR-223 On The Erlotinib-resistant PC9 Cell Lines Via IGF-1R/PI3K/Akt Bypass
25.	Pharmacokinetic/pharmacodynamic Models Of Schedule-dependent Interaction Of Erlotinib And Gemcitabine
26.	Clinical Research Of The Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor In Maintenance Therapy Advanced Non-small Cell Lung Cancer
27.	Effects Of Gemcitabin With Erlotinib On Human Lung Cancer Cell Lines In Different Sequences Administration
28.	Effect Of Epidermal Growth Factor Receptor Inhibitor On Proliferation Of JAK2V617F-positive Cells In Vitro
29.	The Inhibitory Effect Of RNA Interference Or Erlotinib By Blocking Epidermal Growth Factor Receptor Pathway In A549Cells And The Involved Mechanisms
30.	Biological Characteristics And EGFR-TKIs Response In Lung Adenocarcinoma Associated With The EGFR Mutation And Its Subtypes
31.	Clinical Observation Of Erlotinib Combined With Whole Brain Radiotherapy For Non-small Cell Lung Cancer Patients With Brain Metastases
32.	Pharmacologic Inhibition Of EGFR And MTOR Signaling Pathway In C6and Its Glioma Stem Cells
33.	Effects Of Different Sequential Administration Of Erlotinib And Chemotherapy On The NSCLC Cells
34.	Efficacy Of Erlotinib In Advanced Non-small Cell Lung Cancer And Survival Factor Analysis
35.	Cost-Effectiveness Analysis Of Erlotinib Versus CG Chemotherapy In NSCLC First-line Therapy
36.	Pharmacoeconomics Assessment Of Gemcitabine Or Erlotinib Maintenance Therapy For Advanced Non-small-cell Lung Cancer
37.	The Effects Of Erlotinib In The Treatment For Advanced Non-small Cell Lung Cancer
38.	The Efficacy And Prognosis Assessment Of Serum Tumor Markers In NSCLC Treated With Erlotinib
39.	Effect Of Different Combination Of Pemetrexed And Erlotinib On The Lung Adenocarcinoma A549Cells
40.	Chronopharmacokinetics Of Erlotinib And Circadian Rhythms Of Related Metabolic Enzymes In Lewis Tumor-bearing Mice
<<First <Prev Next> Last>> Jump to